Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.03 USD | -0.86% | +6.08% | -1.57% |
May. 14 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-10-31 |
Jennifer Wu
IRC | Investor Relations Contact | - | - |
Ching Chen Chiu
PRN | Corporate Officer/Principal | 55 | 21-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 22-03-31 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 22-03-31 |
John Longo
BRD | Director/Board Member | 55 | 22-03-31 |
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Hung Wei Chen
BRD | Director/Board Member | 43 | 21-10-31 |
Wan Shan Chen
BRD | Director/Board Member | 38 | 21-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,794,433 | 29,496,489 ( 99.00 %) | 0 | 49.50 % |
Stock B | 1 | 29,794,433 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.57% | 1.32B | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- BLTE Stock
- Company Belite Bio, Inc